JP2008520607A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008520607A5 JP2008520607A5 JP2007541794A JP2007541794A JP2008520607A5 JP 2008520607 A5 JP2008520607 A5 JP 2008520607A5 JP 2007541794 A JP2007541794 A JP 2007541794A JP 2007541794 A JP2007541794 A JP 2007541794A JP 2008520607 A5 JP2008520607 A5 JP 2008520607A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- anxiety disorders
- depression
- human subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0425445.4A GB0425445D0 (en) | 2004-11-18 | 2004-11-18 | Novel compositions |
| PCT/EP2005/012368 WO2006053760A1 (en) | 2004-11-18 | 2005-11-16 | Pharmaceutical compositions comprising (+) - (2s, 3s) - 2 - (chlorophenyl) - 3, 5, 5-trimethhyl-2-morpholinol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008520607A JP2008520607A (ja) | 2008-06-19 |
| JP2008520607A5 true JP2008520607A5 (enExample) | 2009-01-15 |
Family
ID=33548507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007541794A Withdrawn JP2008520607A (ja) | 2004-11-18 | 2005-11-16 | （＋）−（２ｓ，３ｓ）−２−（３−クロロフェニル）−３，５，５−トリメチル−２−モルホリノール配合の医薬組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20080008754A1 (enExample) |
| EP (1) | EP1811973A1 (enExample) |
| JP (1) | JP2008520607A (enExample) |
| AR (1) | AR052138A1 (enExample) |
| GB (1) | GB0425445D0 (enExample) |
| PE (1) | PE20061050A1 (enExample) |
| TW (1) | TW200630119A (enExample) |
| WO (1) | WO2006053760A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI436991B (zh) | 2004-11-22 | 2014-05-11 | Euro Celtique Sa | 用於純化反-（-）-△９-四氫大麻酚與反-（＋）-△９-四氫大麻酚之方法 |
| TWI366460B (en) * | 2005-06-16 | 2012-06-21 | Euro Celtique Sa | Cannabinoid active pharmaceutical ingredient for improved dosage forms |
| TWI618821B (zh) * | 2017-04-21 | 2018-03-21 | 萬億股份有限公司 | 製造印刷電路板線路的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9217295D0 (en) * | 1992-08-14 | 1992-09-30 | Wellcome Found | Controlled released tablets |
| CA2253770A1 (en) * | 1998-11-23 | 2000-05-23 | Bernard Charles Sherman | Pharmaceutical composition comprising bupropion hydrochloride |
| US6337328B1 (en) * | 1999-03-01 | 2002-01-08 | Sepracor, Inc. | Bupropion metabolites and methods of use |
| GB0327195D0 (en) * | 2003-11-21 | 2003-12-24 | Smithkline Beecham Corp | Novel use |
| GB0327619D0 (en) * | 2003-11-27 | 2003-12-31 | Smithkline Beecham Corp | New use |
-
2004
- 2004-11-18 GB GBGB0425445.4A patent/GB0425445D0/en not_active Ceased
-
2005
- 2005-11-16 WO PCT/EP2005/012368 patent/WO2006053760A1/en not_active Ceased
- 2005-11-16 AR ARP050104821A patent/AR052138A1/es not_active Application Discontinuation
- 2005-11-16 TW TW094140187A patent/TW200630119A/zh unknown
- 2005-11-16 US US11/719,409 patent/US20080008754A1/en not_active Abandoned
- 2005-11-16 EP EP05807499A patent/EP1811973A1/en not_active Withdrawn
- 2005-11-16 JP JP2007541794A patent/JP2008520607A/ja not_active Withdrawn
- 2005-11-16 PE PE2005001342A patent/PE20061050A1/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8512751B2 (en) | Pharmaceutical compositions for sleep disorders | |
| JP5241228B2 (ja) | 非ステロイド性抗炎症薬、鬱血除去薬および鎮静作用の少ない抗ヒスタミン薬を含む多層錠 | |
| ES2393211T3 (es) | Uso de 2-aminotetralinas sustituidas para la fabricación de un medicamento para la prevención, alivio y/o tratamiento de diversos tipos de dolor | |
| DK2317997T3 (en) | The low dose topiramate / phentermine-COMPOSITION AND METHODS THEREOF FOR USE | |
| JP2024109585A5 (enExample) | ||
| JP2009526021A5 (enExample) | ||
| JP2010522242A5 (enExample) | ||
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| JP5215172B2 (ja) | 乾式直打速崩壊性錠剤 | |
| JP2012532874A5 (enExample) | ||
| CN105431144A (zh) | 阿坎酸制剂、使用阿坎酸制剂的方法以及包含阿坎酸制剂的组合 | |
| JP2013502446A5 (enExample) | ||
| JP2013541583A5 (enExample) | ||
| JP2016520653A5 (enExample) | ||
| NZ613291A (en) | Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof | |
| JP2005508872A5 (enExample) | ||
| JP2006518731A5 (enExample) | ||
| US20240139224A1 (en) | Treatment of sleep apnea with a combination of a carbonic anhydrase inhibitor and an aldosterone antagonist | |
| JP2010500284A5 (enExample) | ||
| JP2008520607A5 (enExample) | ||
| WO2012104641A2 (en) | Pharmaceutical formulation | |
| JP2012502105A5 (enExample) | ||
| WO2015008825A1 (ja) | 口腔内崩壊錠 | |
| JP2015515971A5 (enExample) | ||
| JP2019514978A5 (enExample) |